Dr. Ford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
81 N Mario Capecchi Dr
Salt Lake City, UT 84113Phone+1 801-442-3229
Summary
- Dr. James Ford is a pediatric hematologist/oncologist in Omaha, NE and is affiliated with multiple hospitals in the area, including Nebraska Medicine - Nebraska Medical Center and Children's Hospital and Medical Center. He received his medical degree from Des Moines University College of Osteopathic Medicine. He also speaks multiple languages, including Spanish and Portuguese. He specializes in pediatric hematologic oncology.
Education & Training
- University of ColoradoFellowship, Pediatric Hematology/Oncology, 2011 - 2014
- Children's Hospital Medical Center of Akron/NEOMEDResidency, Pediatrics, 2008 - 2011
- Des Moines University College of Osteopathic MedicineClass of 2008
Certifications & Licensure
- UT State License 2023 - 2026
- NE State License 2014 - 2024
- CO State License 2011 - 2015
- OH State License 2008 - 2011
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Academic faculty of the month Voted on by Residents at Childrens hospital Omaha September 2017 and December 2018
- Abstract Achievement Award ASH, 2013
- Excellence in resident teaching award Akron Children�s Hospital, 2011
- Join now to see all
Clinical Trials
- Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children Start of enrollment: 2019 May 02
Publications & Presentations
PubMed
- 100 citationsInhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics In Vitro and In Vivo, Independent of p53 FunctionalityAnnemie A. Van Linden, Dmitry Baturin, James B. Ford, Susan Fosmire, Lori A. Gardner
Molecular Cancer Therapeutics. 2013-12-01 - 33 citationsAZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repairJames B. Ford, Dmitry Baturin, Tamara M. Burleson, Annemie A. Van Linden, Yong-Mi Kim
Oncotarget. 2015-08-14 - 5 citationsBreast Cancer and Non-Hodgkin Lymphoma in a Young Male with Cowden Syndrome.Robert Tanner Hagelstrom, James B. Ford, Gwendolyn M. Reiser, Marilu Nelson, Diane L. Pickering
Pediatric Blood & Cancer. 2016-03-01
Journal Articles
- Breast Cancer and Non-Hodgkin Lymphoma in a Young Male with Cowden SyndromeHagelstrom RT, Ford J, Reiser GM, Nelson M, Pickering DL, Althof PA, Sanger WG, Coccia PF, Pediatric Blood & Cancer, 1/1/2016
- Inhibition of Wee1 sensitizes cancer cells to anti-metabolite chemotherapeutics in vitro and in vivo, independent of p53 functionalityVan Linden A, Baturin D, Fosmire S, Ford J, Gardner L, Korch C, Reigan P, Porter C, Mol Cancer Ther, 1/11/2013
Abstracts/Posters
- Incidence and characteristics of Post-transplant lymphoproliferative disorder in pediatric patients following intestinal transplantErin Oeltjen, Makayla Schissel MPH, Kelly Erickson MPH, Shaheed Merani MD PhD, James Ford DO, ASPHO, Pittsburgh, PA, 5/5/2022
- Outcome of Post Solid Organ Transplant Burkitt Lymphoma (PSOT-BL): A Report from the Pediatric PTLD Collaborative (PPC)Zeinab Afify, MD, Manuela Orjuela, MD, ScM, Christine Moore Smith, MD, Mansi Dalal, MD, James B. Ford, DO, Pallavi Pillai, Joanna Robles, MD, Sonika Reddy, MD, Sarah M..., ASH 63rd annual meeting, Atlanta, GA, 12/8/2021
- Children are 6 times more likely that adults to develop Post-Transplant Lymphoproliferative Disease.Ford JB, Sanmann J, Erickson K, Bast M, Grant W, Shostrom V, Langnas A, Greiner T, Coccia P, BJH; 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, The Netherlands, 1/1/2018
- Join now to see all
Lectures
- Children are 6 times more likely that adults to develop Post-Transplant Lymphoproliferative Disease.Rotterdam, The Netherlands - 1/1/2018
- Identification of Congenital Marrow Failure Syndromes in Children and Adults. Presented at Bone marrow failure disease symposium: A multidisciplinary approach to enhan...Omaha, NE - 1/1/2017
- Difficulties facing families with a child undergoing cancer treatment.Green Bay, WI - 1/1/2017
- Join now to see all
Grant Support
- Tropolones as a novel therapeutic strategy for OsteosarcomaHyundai Hope on Wheels2021–2024
Committees
- Panel member, NCCN Pediatric Aggresive Mature B-Cell Lymphoma 2019 - Present
- member, Children's Oncology Group Non-Hodgkin's Lymphoma group
Professional Memberships
- Member
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: